BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30121147)

  • 1. Current choices and prospects in management of postoperative esophageal cancer patients.
    Tu CC; Hsu PK
    Asian J Surg; 2019 Jan; 42(1):81-84. PubMed ID: 30121147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
    Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
    BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimodality Approach for Esophageal Malignancies.
    Watkins AA; Zerillo JA; Kent MS
    Surg Clin North Am; 2021 Jun; 101(3):453-465. PubMed ID: 34048765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upfront surgery and pathological stage-based adjuvant chemoradiation strategy in locally advanced esophageal squamous cell carcinoma.
    Chen HS; Hsu PK; Liu CC; Wu SC
    Sci Rep; 2018 Feb; 8(1):2180. PubMed ID: 29391589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.
    Burt BM; Groth SS; Sada YH; Farjah F; Cornwell L; Sugarbaker DJ; Massarweh NN
    Ann Surg; 2017 Aug; 266(2):297-304. PubMed ID: 27501170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definitive chemoradiotherapy for esophageal carcinoma.
    Cooper SL; Russo JK; Chin S
    Surg Clin North Am; 2012 Oct; 92(5):1213-48. PubMed ID: 23026279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant (postoperative) therapy for esophageal cancer.
    Ku GY; Ilson DH
    Thorac Surg Clin; 2013 Nov; 23(4):525-33. PubMed ID: 24199702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer.
    Tiesi G; Park W; Gunder M; Rubio G; Berger M; Ardalan B; Livingstone A; Franceschi D
    J Surg Res; 2017 Aug; 216():65-72. PubMed ID: 28807215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of advanced-stage operable esophageal cancer.
    Bharat A; Crabtree T
    Surg Clin North Am; 2012 Oct; 92(5):1179-97. PubMed ID: 23026277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy or chemoradiotherapy for locally advanced esophageal cancer.
    Smithers BM; Thomson I
    Thorac Surg Clin; 2013 Nov; 23(4):509-23. PubMed ID: 24199701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemoradiotherapy for esophageal carcinoma.
    Zhang X; Watson DI; Jamieson GG; Bessell JR; Devitt PG
    Dis Esophagus; 2005; 18(2):104-8. PubMed ID: 16053485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
    Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
    Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.
    Chen Y; Hao D; Wu X; Xing W; Yang Y; He C; Wang W; Liu J; Wang J
    Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant Treatment for Locally Invasive Esophageal Cancer.
    Iams WT; Villaflor VM
    World J Surg; 2017 Jul; 41(7):1719-1725. PubMed ID: 28271259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Timing of esophagectomy in multimodal therapy of esophageal cancer: Impact of time interval between neoadjuvant therapy and surgery on outcome and response].
    Müller AK; Lenschow C; Palmes D; Senninger N; Hummel R; Lindner K
    Chirurg; 2015 Sep; 86(9):874-80. PubMed ID: 25662991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment strategies for esophageal cancer.
    Nieman DR; Peters JH
    Gastroenterol Clin North Am; 2013 Mar; 42(1):187-97. PubMed ID: 23452638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should Multidisciplinary Treatment Differ for Esophageal Adenocarcinoma Versus Esophageal Squamous Cell Cancer?
    Cools-Lartigue J; Ferri L
    Ann Surg Oncol; 2019 Apr; 26(4):1014-1027. PubMed ID: 30675706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic strategies for advanced respectable esophageal cancer].
    Kitagawa Y
    Nihon Geka Gakkai Zasshi; 2008 Nov; 109(6):333-7. PubMed ID: 19068714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choosing the best treatment for esophageal cancer : criteria for selecting the best multimodal therapy.
    Hölscher AH; Bollschweiler E
    Recent Results Cancer Res; 2012; 196():169-77. PubMed ID: 23129373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
    Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
    Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.